Our Healing Chamber Centers will treat patients with active malignancies. However, such patients must remain under the care of the specialist oncologists. While we endorse intermittent applications of HBOT as a valuable adjunctive therapy, HBOT CANNOT BE USED AS A SUBSTITUTE FOR STANDARD ONCOLOGY RESPONSE TO CANCER.
When to ask your oncologist about hyperbaric oxygen therapy … ? IMMEDIATELY.
Penn Study Finds Hyperbaric Oxygen Treatments Mobilize Stem Cells
Science Daily — According to a study to be published in the American Journal of Physiology – Heart and Circulation Physiology, a typical course of hyperbaric oxygen treatments increases by eight-fold the number of stem cells circulating in a patient’s body. Stem cells, also called progenitor cells are crucial to injury repair.
The study currently appears on-line and is scheduled for publication in the April 2006 edition of the American Journal.
Stem cells exist in the bone marrow of human beings and animals and are capable of changing their nature to become part of many different organs and tissues. In response to injury, these cells move from the bone marrow to the injured sites, where they differentiate into cells that assist in the healing process.
The movement, or mobilization, of stem cells can be triggered by a variety of stimuli – including pharmaceutical agents and hyperbaric oxygen treatments. Where as drugs are associated with a host of side effects, hyperbaric oxygen treatments carry a significantly lower risk of such effects.
“This is the safest way clinically to increase stem cell circulation, far safer than any of the pharmaceutical options,” said Stephen Thom, MD, Ph.D., Professor of Emergency Medicine at the University of Pennsylvania School of Medicine and lead author of the study. “This study provides information on the fundamental mechanisms for hyperbaric oxygen and offers a new theoretical therapeutic option for mobilizing stem cells.”
“We reproduced the observations from humans in animals in order to identify the mechanism for the hyperbaric oxygen effect,” added Thom. “We found that hyperbaric oxygen mobilizes stem/progenitor cells because it increases synthesis of a molecule called nitric oxide in the bone marrow. This synthesis is thought to trigger enzymes that mediate stem/progenitor cell release.”
Source: University of Pennsylvania School of Medicine
Date: December 28, 2005
The Miracle of Carson C
A Tribute to Ellie
Invasive fungus is common with little leukemia patients and compromised immune system adults. In 1987, Children’s Hospital primary oncologist for Carson wrote:
“he has had a miraculous recovery with hyperbaric oxygen contributing to this response. This infection is usually fatal, yet Carson has survived and at present remains on chemotherapy.”
Carson’s health insurance agreed that Carson should continue with HBOT treatments throughout 2007 to ensure that the virulent fungus mucor did not return. He continued with his chemotherapy at Rady’s Childrens’ Hospital, San Diego and had regular HBOT sessions at the San Diego Center. To learn about the touch’n’go saving of Carson, the cooperation of Children’s Hospital specialist physicians and surgeons, and the clinical details of his HBOT treatments. For the clinical details of how he was treated and why HBOT kills fungus click Toxic Mold & Fungus
September 2007. During grand-rounds review at S.D. Children’s Hospital, Carson’s progress was reviewed. It was noted that he was the only little patient that had none of the usual sequels to his maintenance chemotherapy. Unlike the other little patients, Carson’s hair was growing thick and strong, he had no aches or pains and was full of bouncing vitality. In essence, a “normal” little boy. The question was raised “What is Carson doing that these other children are not doing?” The answer was “three HBOT sessions each week!”
While Carson’s HBOT Rx was to prevent the return of the fungus, the fact that his progress was greater than other little patients begs an answer to the question “should HBOT be a standard an adjunctive therapy for leukemia and lymphoma patients?” The answer could well lie in the fact that stem cells from bone marrow transplants are a common survival approach but hard to find –
“As many as 16,000 leukemia patients require a bone marrow transplant but have no matched relative or can’t find a match in the national bone marrow registry – Mary J Laughlin, M.D. Comprehensive Cancer Center and University Hospital of Cleveland Ireland Cancer Center. November 30, 2004
Carson is producing his own healthy stem cells because of his HBOT treatments!
Sadly, some of our patients start too late.
We present the following clip about Ellie Potvin for your consideration, along with the words of her mother Amy. This moving tribute is included on this site to prevent Ellie from becoming another statistic. Numbers do not cause the heartache that little faces do.
Please be aware that these images are copyright to www.Liftupfoundation.org
Ellie fought for 2 years and was given hard core amounts of chemo and radiation using a 30 year old protocol to start the fight. I was disgusted!
Ellie had stage 4 rhabdomyosarcoma diagnosed at 6 years of age in July 2008. It was only after the Oncologists sent her home to die, April of 2010, that God Blessed my family with HBOT treatment.
I firmly believe that Ellie would be alive today should we have started with this immune boosting treatment. Though I am sad to say that we started this cancer healing therapy too late. But, I was blessed to have been given more days with Ellie through HBOT. Ellie fought till June 23, 2010.
Ellie has a twin sister, Grace. I can tell you with great HOPE … that should Grace be diagnosed tomorrow … I would start with HBOT treatment. It would be through great difficulty to poison my child again. The chemotherapy caused her such great suffering above and beyond the cancer.
Please look into alternative treatments. I have started the Lift Up Foundation and pray that in years to come it will support and educate families like yours on HBOT and other alternative treatments.”
2 Myers et al, “A preliminary report on hyperbaric oxygen in the relief migraine headaches” Headaches, 1995 Apr; 35(4): 197-9. 3 Lance, et al, “Changes in the permeability of the blood-brain barrier under hyperbaric conditions” Aviat’ Space Environ’ Med, 1978 Jul;49(7):890-4. 4 Feldmeier, Professor of Oncology, Medical College of Ohio. “Does Hyperbaric Oxygenation accelerate cancer? 2002. 5 Thom, et al, “Stem Cell Mobilization by hyperbaric oxygen.” Am J Physiol Heart Circ Physiol 290: H1378, 2006. (information current as of September 20)